GlassScriptPhysician profile
Rakshanda Aslam
NPI 1720260268
$22,161.48
in general payments reported to CMS, 2019-2025
52 companies · $2,946 in 2025
The $2,946 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,871 · 2020: $2,770 · 2021: $3,796 · 2022: $2,951 · 2023: $3,349 · 2024: $3,478 · 2025: $2,946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,773.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $3,244.53 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $2,744.42 | 2019-2025 | Qulipta, Linzess, Viberzi |
| Astrazeneca Pharmaceuticals LP | $1,748.79 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $1,423.95 | 2019-2025 | Evenity, Prolia |
| Lilly USA, LLC | $1,319.40 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $1,141.73 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $940.60 | 2019-2025 | Jardiance, Ofev, Tradjenta |
| Gilead Sciences, INC. | $804.13 | 2019-2025 | |
| Glaxosmithkline, LLC. | $780.78 | 2020-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astellas Pharma US INC | $729.52 | 2019-2025 | Veozah, Myrbetriq |
| Amarin Pharma, INC. | $648.98 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $623.68 | 2019-2024 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $609.17 | 2019-2025 | Xifaxan, Trulance |
| Teva Pharmaceuticals USA, INC. | $589.94 | 2019-2024 | Austedo Xr, Austedo, Ajovy |
| Kowa Pharmaceuticals America, INC. | $560.95 | 2019-2023 | Livalo, Seglentis |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $460.51 | 2019-2025 | |
| Allergan, INC. | $405.33 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $387.01 | 2019-2025 | Trintellix |
| Exact Sciences Corporation | $372.13 | 2023-2025 | Cologuard Collection Kit |
| Dexcom, INC. | $278.60 | 2023-2025 | Dexcom G6 Transmitter |
| Inspire Medical Systems, INC. | $276.19 | 2024-2025 | Inspire |
| Novartis Pharmaceuticals Corporation | $251.70 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $226.96 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Bayer Healthcare Pharmaceuticals INC. | $226.44 | 2021-2025 | |
| Abbott Laboratories | $129.01 | 2024-2025 | Freestyle Libre 3 |
| Sanofi Pasteur INC. | $108.28 | 2019-2024 | |
| Currax Pharmaceuticals LLC | $107.03 | 2020-2025 | Contrave |
| Radius Health, INC. | $94.70 | 2020-2025 | Tymlos |
| Biohaven Pharmaceutical Holding Company LTD. | $93.67 | 2022 | |
| Daiichi Sankyo INC. | $80.18 | 2024-2025 | Injectafer |
| Ibsa Pharma INC. | $62.94 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $61.97 | 2024-2025 | Gemtesa |
| Aimmune Therapeutics, INC. | $60.43 | 2025 | Zenpep |
| Genentech USA, INC. | $53.56 | 2019-2021 | |
| Ultragenyx Pharmaceutical INC. | $49.90 | 2022 | |
| Esperion Therapeutics, INC. | $47.01 | 2025 | Nexletol |
| Axsome Therapeutics, INC. | $44.01 | 2025 | Symbravo, Auvelity |
| Optinose US, INC. | $38.96 | 2019-2025 | |
| Biohaven Pharmaceuticals, INC. | $36.97 | 2021 | |
| Paratek Pharmaceuticals, INC. | $36.72 | 2021-2024 | Nuzyra |
| Eisai INC. | $36.42 | 2019-2020 | |
| Upsher-Smith Laboratories LLC | $36.33 | 2021 | |
| Pulmonx Corporation | $34.42 | 2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Phathom Pharmaceuticals, INC. | $29.23 | 2025 | Voquezna |
| Grifols USA, LLC | $19.14 | 2020 | |
| Medicure Pharma INC. | $18.13 | 2022 | |
| Ironwood Pharmaceuticals, INC | $17.41 | 2019 | |
| Impel Pharmaceuticals INC. | $15.75 | 2022 | |
| Scilex Pharmaceuticals INC. | $15.57 | 2019 | |
| Idorsia Pharmaceuticals US INC | $14.70 | 2024 | Quviviq |
| Medtronic, INC. | $12.26 | 2021 | |
| Biogen, INC. | $11.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rakshanda Aslam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.